Arcturus to present OTC deficiency Phase 2 data Sept. 23
Arcturus Therapeutics (Nasdaq: ARCT) will host a virtual presentation on Wednesday, Sept. 23, 2026, at 4:30 p.m. ET covering OTC deficiency Phase 2 clinical data and an update on its mRNA liver therapeutics platform.